We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury

By HospiMedica International staff writers
Posted on 27 Aug 2026

Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. More...

Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws and refrigerated handling, which limits home or point‑of‑care use. Simpler, minimally invasive testing could expand access to earlier diagnosis and monitoring. To help address this challenge, researchers have developed a painless microneedle skin patch that captures kidney injury biomarkers.

Engineers at the McKelvey School of Engineering at Washington University in St. Louis, working with Washington University School of Medicine and Texas A&M University, created a patch designed for quick, safe sampling from the skin. The device aims to support earlier identification of kidney injury and to enable monitoring outside traditional laboratories. The approach focuses on stable, on‑skin biomarker capture to simplify logistics and expand access.

The technology uses microneedles coated with a metal‑organic framework (MOF) to sample interstitial fluid. The MOF forms a protective shell that both detects and preserves antibodies targeting neutrophil gelatinase–associated lipocalin (NGAL), an early, clinically validated biomarker of acute kidney injury. The patch captured biomarkers for accurate quantification and maintained antibody function for up to four weeks at 50°C without refrigeration, supporting potential use in home or resource‑limited settings.

Findings were published in Advanced Materials on August 5, 2026. According to the team, this is the first demonstration that encapsulating biomolecules on microneedles can preserve their biological functions. The work builds on earlier microneedle patches and adapts the platform to achieve higher sensitivity and a broader dynamic range while addressing cold‑chain constraints that limit current NGAL testing. NGAL rises in blood within hours of kidney injury, but dependence on phlebotomy and refrigerated logistics has impeded its use for at‑home or remote monitoring.

“This metal-organic framework encapsulation is a simple and highly effective way to create microneedle sensors that are resilient to environmental challenges and provide a scalable path to minimally invasive biosensing for at-home or remote health monitoring,” said Srikanth Singamaneni, Lilyan & E. Lisle Hughes Professor in the Department of Mechanical Engineering & Materials Science at Washington University in St. Louis.

Related Links
Washington University in St. Louis


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
12-Channel ECG
CM1200B
Resorbable Bovine Collagen Membrane
GenDerm
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.